초음파 젤 시장 : 제품 유형, 물리적 상태, 점도 레벨, 조성, 용도, 최종 사용자, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Ultrasound Gels Market is projected to grow by USD 220.46 million at a CAGR of 5.75% by 2032.

The ultrasound gels market is anchored by a simple but clinically essential function: creating an acoustic coupling layer that removes air between the transducer and the skin so ultrasound waves can transmit efficiently. Demand is supported by the expanding use of diagnostic ultrasound across radiology, obstetrics and gynecology, cardiology, emergency medicine, vascular imaging, anesthesia, physiotherapy, and point-of-care ultrasound settings.

Market momentum is increasingly shaped by infection prevention requirements, procedure growth, and the shift toward portable and handheld ultrasound systems. Buyers are evaluating gel products not only on viscosity, conductivity, and image clarity, but also on sterility, packaging integrity, preservative profile, traceability, and compatibility with probes, covers, and disinfection workflows. This makes ultrasound gel a clinically relevant consumable within broader diagnostic imaging, procedural guidance, and patient safety strategies.

Transformative Shifts in the Ultrasound Gel Landscape

The landscape is shifting from commodity purchasing toward evidence-based product selection. Healthcare facilities are differentiating between non-sterile ultrasound gel for intact skin applications and sterile ultrasound gel for invasive, surgical, neonatal, mucosal, or high-risk procedures, reflecting infection prevention guidance and documented contamination events involving aqueous medical products.

Another major shift is the rise of point-of-care ultrasound, which has moved imaging closer to emergency departments, intensive care units, ambulatory clinics, home care models, and remote medical environments. This decentralization increases demand for formats that reduce waste, support single-patient use, and withstand distributed inventory conditions. Sustainability is also becoming a procurement factor, with attention on bottle recyclability, pouch formats, reduced plastic use, lower transport burden, and responsible manufacturing practices.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is influencing ultrasound gel demand indirectly but materially. AI-assisted ultrasound systems improve image acquisition, automate measurements, and support less-experienced users, which can increase ultrasound utilization in primary care, emergency medicine, outpatient clinics, and resource-constrained settings. As scan activity expands, consumption of acoustic coupling agents also rises across both conventional cart-based and handheld imaging workflows.

AI is also changing quality control and supply chain management. Manufacturers can use machine vision, predictive maintenance, and batch analytics to improve fill accuracy, packaging inspection, label verification, and contamination risk monitoring. For healthcare systems, AI-enabled procurement tools can forecast gel consumption by modality, department, seasonality, and procedure mix, reducing stockouts while supporting compliance with sterile gel usage policies and product rotation controls.

Key Regional Insights: Global Ultrasound Gel Demand Patterns

Asia-Pacific is a dynamic arena for ultrasound gels due to expanding diagnostic imaging capacity, rising maternal health programs, and rapid adoption of portable ultrasound across China, India, Japan, South Korea, Australia, and ASEAN healthcare systems. Local manufacturing capacity and price-sensitive procurement remain important, while premium sterile and specialty gels gain traction in tertiary hospitals, interventional departments, and advanced procedure settings.

North America benefits from mature ultrasound utilization, strong outpatient imaging networks, and strict infection prevention expectations in the United States and Canada. Europe is shaped by Medical Device Regulation requirements, sustainability targets, and quality-focused hospital purchasing, encouraging stronger documentation, traceability, and material responsibility. Latin America, led by Brazil and Mexico, is expanding access to ultrasound in public and private care, while the Middle East is investing in advanced hospitals, specialty clinics, and imaging infrastructure. Africa shows long-term opportunity as ultrasound is widely valued for maternal care, emergency triage, and low-radiation diagnostics, though access, distribution reliability, trained workforce availability, and affordability remain decisive factors for ultrasound gel adoption.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are benefiting from hospital network expansion, maternal health initiatives, and the use of ultrasound in community and private care settings, supporting demand for practical, cost-efficient gel formats. GCC countries are characterized by investment in premium healthcare infrastructure, international accreditation standards, and demand for sterile and procedure-specific gel formats in advanced hospitals, specialty centers, and medical tourism hubs.

The European Union is highly influenced by MDR compliance, product documentation, post-market surveillance expectations, and sustainability-oriented procurement. BRICS economies combine large patient populations with growing domestic device and consumables manufacturing capacity, making them important both as demand centers and supply bases for ultrasound consumables. G7 markets set quality, safety, and innovation benchmarks through advanced imaging adoption and robust healthcare procurement systems, while NATO member countries add a defense and emergency medicine dimension where portable ultrasound and dependable consumables are relevant to field care, humanitarian response, and medical readiness.

Key Country Insights for Ultrasound Gel Market Expansion

The United States remains a leading demand center due to high ultrasound procedure utilization, outpatient imaging growth, and strong emphasis on infection control. Canada shows stable demand through publicly funded healthcare procurement and growing point-of-care ultrasound adoption, while Mexico and Brazil benefit from private hospital growth, wider diagnostic access, and expanding use of ultrasound in obstetric, emergency, and specialty care.

In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize regulatory compliance, clinical safety, product documentation, and sustainability, while Russia maintains demand through hospital imaging needs and domestic supply priorities. China and India represent major scale opportunities driven by large patient populations, expanding diagnostic networks, and government focus on healthcare access. Japan and South Korea favor high-quality imaging ecosystems, advanced hospital workflows, and strict quality expectations, and Australia shows steady demand supported by established radiology, obstetric, emergency, rural healthcare, and point-of-care ultrasound applications.

Actionable Recommendations for Industry Leaders

Industry leaders should segment portfolios by clinical risk: non-sterile gel for intact skin, sterile single-use gel for invasive or high-risk applications, and specialty formulations for procedures requiring specific viscosity, conductivity, low residue, or enhanced patient comfort. Clear labeling, validated shelf life, lot traceability, tamper-evident packaging, and compatibility documentation should be treated as strategic differentiators rather than compliance basics.

Manufacturers should invest in resilient packaging, contamination control, sustainable materials, and regional supply redundancy. Commercial teams should support healthcare buyers with education on appropriate gel use, procedure-based selection, and total cost of ownership, including waste reduction, infection risk mitigation, workflow efficiency, and simplified inventory management across centralized and point-of-care environments.

Research Methodology

This executive assessment is based on secondary research from regulatory guidance, infection prevention recommendations, medical device quality standards, hospital procurement trends, and publicly available evidence on ultrasound utilization. Sources considered include medical device regulatory frameworks such as FDA requirements and the European MDR, as well as clinical guidance from infection prevention authorities and professional imaging organizations.

The analysis applies market triangulation across demand drivers, procedure trends, product categories, regional healthcare investment, and supply-side capabilities. Findings are validated through consistency checks across clinical use cases, product risk classifications, contamination prevention practices, packaging requirements, and documented procurement priorities affecting ultrasound gel adoption.

Conclusion: Strategic Outlook for Ultrasound Gels

Ultrasound gel remains a critical consumable in diagnostic and procedural imaging, but the market is evolving beyond basic acoustic coupling. Adoption is increasingly tied to point-of-care ultrasound, infection prevention, sterile packaging, regulatory quality, traceability, and sustainable procurement.

Companies that align product development with clinical risk, regional needs, and data-driven supply chain planning are best positioned to meet durable demand. The strongest opportunities will come from combining dependable image performance with safety, compliance, contamination control, and formats designed for modern ultrasound workflows.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Ultrasound Gels Market, by Product Type

• 7.1. Standard Gels
  • 7.1.1. Water-based Gels
  • 7.1.2. Hypoallergenic Gels
• 7.2. Sterile Gels
  • 7.2.1. Single-use Sterile Sachets
  • 7.2.2. Multi-dose Sterile Bottles

8. Ultrasound Gels Market, by Physical State

• 8.1. Liquid Gels
• 8.2. Semi-solid Gels

9. Ultrasound Gels Market, by Viscosity Level

• 9.1. High Viscosity
• 9.2. Low Viscosity
• 9.3. Medium Viscosity

10. Ultrasound Gels Market, by Composition

• 10.1. Propylene Glycol-based
• 10.2. Carbomer-based
• 10.3. Natural Polymer-based

11. Ultrasound Gels Market, by Application

• 11.1. Diagnostic Imaging
  • 11.1.1. General Radiology
  • 11.1.2. Cardiovascular Ultrasound
  • 11.1.3. Musculoskeletal
• 11.2. Interventional Procedures
  • 11.2.1. Biopsy Guidance
  • 11.2.2. Needle Localization
  • 11.2.3. Vascular Access
• 11.3. Therapeutic Ultrasound
• 11.4. Veterinary Applications

12. Ultrasound Gels Market, by End-User

• 12.1. Clinics
• 12.2. Diagnostic Imaging Centers
• 12.3. Hospitals
• 12.4. Research & Academic Institutes
• 12.5. Ambulatory Surgical Centers

13. Ultrasound Gels Market, by Distribution Channel

• 13.1. Online
• 13.2. Offline

14. Ultrasound Gels Market, by Region

• 14.1. Asia-Pacific
• 14.2. North America
• 14.3. Latin America
• 14.4. Europe
• 14.5. Middle East
• 14.6. Africa

15. Ultrasound Gels Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Ultrasound Gels Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025

18. Company Profiles

• 18.1. AiM Medical Technologies, LLC
• 18.2. Aquasonic Ultrasound Gels Inc.
• 18.3. Cardinal Health, Inc.
• 18.4. Ceracarta S.p.A.
• 18.5. Compass Health Brands
• 18.6. EDM Medical Solutions
• 18.7. General Electric Company
• 18.8. HR Pharmaceuticals, Inc.
• 18.9. Jorgensen Laboratories, LLC
• 18.10. Medline Industries, Inc.
• 18.11. NEXT Medical Products Company
• 18.12. NIHON KOHDEN CORPORATION
• 18.13. P.W. Coole & Son Ltd Trading
• 18.14. Parker Laboratories Inc.
• 18.15. Phyto Performance Italia srl
• 18.16. Rohde Produits
• 18.17. Safersonic
• 18.18. Steroplast Healthcare Limited
• 18.19. Telic Group
• 18.20. Trivitron Healthcare Pvt. Ltd
• 18.21. Turkuaz Health